A Phase IIIb open-label, randomised, multi-centre primary immunization study to evaluate the immunogenicity and safety of GSK Biologicals’ HPV-16/18 L1 VLP AS04 vaccine when administered intramuscularly according to alternative 2-dose schedules in 9 – 14 year old healthy females compared to the standard 3-dose schedule for GSK Biologicals’ HPV-16/18 L1 VLP AS04 vaccine in 15…
Diabetes Medication with Implantable Device Study
A Phase 3, Randomized, Active Comparator, Double-Blind, Multi-Center Study to Compare the Efficacy, Safety and Tolerability of ITCA 650 to Sitagliptin as Add-on Therapy to Metformin in Patients with Type 2 Diabetes. Register Today!
Meningitis B Vaccine
A Phase 3, Randomized, Active-Controlled, Observer-Blinded Trial To Assess The Lot Consistency, Safety, Tolerability, And Immunogenicity Of A Meningococcal Serogroup B Bivalent Rlp2086 Vaccine In Healthy Subjects Aged 10 To <19 Years. Register Today!
H7N1 Pandemic Influenza Vaccine (Older Adult)
A phase II observer-blind, randomized, controlled, multi-center trial to evaluate the safety and immunogenicity of different formulations of monovalent Influenza A/mallard/Netherlands/12/2000 NIBRG-63 (H7N1) vaccine manufactured in Quebec, Canada with AS03 adjuvant, given as a two-dose series to adults 65 years of age and older. Register Today!
H7N1 Pandemic Influenza Vaccine (Adults)
A phase I/II single-blind, randomized, controlled, multi-center trial to evaluate the safety and immunogenicity of different formulations of monovalent Influenza A/mallard/Netherlands/12/2000 NIBRG-63 (H7N1) vaccine manufactured in Quebec, Canada with and without AS03 adjuvant, given as a two-dose series to adults 21 to 64 years of age. Register Today!
Moderate to Severe COPD Treatment
Double-blind, Randomized, Placebo-controlled, Parallel-group, Phase IV Study to Evaluate the Effect of Aclidinium Bromide on Long-Term Cardiovascular Safety and COPD Exacerbations in Patients with Moderate to Very Severe COPD. Register Today!
Pediatric influenza vaccine
A Phase III, Stratified, Randomized, Observer Blind, Controlled, Multicenter Clinical Study to Evaluate the Safety, Immunogenicity and Efficacy of an Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine Compared to Non-Adjuvanted Comparator Influenza Vaccine in Children ≥6 to < 72 Months of Age. Register Today!
Phase 3, randomized, double-blind, active-controlled, parallel arm study of PRC-062 (hydromorphone/naloxone controlled release capsules) in patients with chronic non-cancer pain. To see if IP is as effective as hydromorph contin. Register Today!
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Multicenter, Multi-National Study For Evaluation Of Efficacy And Safety Of Du-176b Versus Warfarin In Subjects With Atrial Fibrillation – Effective Anticoagulation With Factor Xa Next Generation In Atrial Fibrillation. Register Today!
A phase III, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of the fixed dose combination of Empagliflozin 10 mg/Linagliptin 5 mg compared with Empagliflozin 10 mg alone and the efficacy and safety of Empagliflozin 25 mg/Linagliptin 5 mg compared with Empagliflozin 25 mg alone each administered orally once daily over…